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ABSTRACT
Nurses are primarily concerned with the health and safety of their
patients. Counterfeit medicines pose a serious threat to patient safetyl
As frontline, direct health care providers, nurses can help with the
problem of counterfeit medicines by educating patients and other
health care providers about the dangers of counterfeit medicines, by
monitoring and assessing patients for evidence of counterfeit medi-
cines, by supporting regulatory efforts to prevent the introduction of
counterfeit medicines into the drug distribution chain, and by report-
ing suspected cases to the appropriate authorities.
INTRODUCTION
Counterfeit drugs pose a serious risk to the safety of patients who
take them. Counterfeit drugs are not only unsafe, ineffective, and fail
to treat the patient's disease, but can also result in poisoning, disabil-
ity, and death.1 Counterfeit medicines also affect the health of the
public at large by increasing the risk for antimicrobial resistant organ-
isms. 2
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1. INT'L COUNCIL OF NURSES, NURSES FOR PATIENT SAFETY: TARGETING COUNTERFEIT
AND SUBSTANDARD MEDICINES 5 (2005), available at http://www.rcna.org.au/con-
tent/ind_2005_e_final.doc.
2. Id. at 17.
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The current counterfeit drug problem is a global one, evidenced
by counterfeit drug operations having been uncovered in nearly all
countries. 3 Although the exact prevalence rates in the United States
are unknown, "outside the [United States] drug counterfeiting is...
widespread and affect[s] both developing and developed countries."4
"In some countries, more than half of the drug supply may consist of
counterfeit drugs."5 Patients in these countries have a better chance of
receiving a fake medicine than a real one.6 For example, one recent
article reported that the majority of anti-malarial drugs in Africa are
likely counterfeit.7
Counterfeit medicines are more commonly found "in countries
with weak drug regulation control and enforcement, scarcity [in
the] ... supply of basic medicines, unregulated markets, and unaf-
fordable prices."8 Within the United States, the extensive federal and
state regulatory oversight system has resulted in various measures be-
ing taken by drug manufacturers, distributors, and pharmacies to pre-
vent counterfeiting; thus the problem is not as rampant.9 However, the
FDA "has recently seen an increase in counterfeiting activities as well
as increased sophistication in the methods used to introduce" counter-
feits into the U.S. pharmaceutical system. 10
ISSUES IN THE UNITED STATES
Responding to the increasing threat of counterfeit drugs, the FDA
formed a Counterfeit Drug Task Force in July 2003.11 The goals of
the task force are to prevent the introduction of counterfeit drugs and
biologics into the U.S. drug distribution chain, to provide strategies to
facilitate the identification of counterfeit drugs, to minimize consum-
ers' risk and exposure to counterfeit drugs, and to avoid the addition
3. FDA, COMBATING COUNTERFEIT DRUGS 2 (2004), available at http://www.fda.
gov/counterfeit/.
4. Id.
5. Id.
6. Id.
7. Id.
8. World Health Org. [WHO], Fact Sheet No. 275: Substandard and Counterfeit Medi-
cines (2003), http:www.who.int/mediacentre/factsheets/2003/fs275/en [hereinafter Fact Sheet
No. 275].
9. FDA, supra note 3, at 1.
10. Id.; see also FDA, COMBATING COUNTERFEIT DRUGS: A REPORT OF THE FOOD AND
DRUG ADMINISTRATION ANNUAL UPDATE (2005), available at http://www.fda.gov/oc/ initia-
tives/counterfeit/update2005.html.
11. FDA, supra note 3, at i.
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of unnecessary costs to the prescription drug distribution system or
unnecessary restrictions on lower-cost sources of drugs. 12 Some task
force strategies include using advanced technology to protect legiti-
mate drugs against tampering, securing business practices amongst
participants in the drug supply chain, increasing regulatory oversight
and enforcement, creating rapid alert and response systems, develop-
ing education and public awareness programs, and increasing interna-
tional collaboration. '
3
Since the implementation of the task force, the FDA has an-
nounced significant progress in the battle against counterfeit drugs.14
In 2004, the FDA conducted fifty-eight counterfeit drug investiga-
tions. 5 This represents a dramatic increase from the thirty cases in-
vestigated in 2003.16 The FDA attributes the increase to "heightened
vigilance and awareness by all parties in the diug distribution sys-
tem,... more effective coordination [between] state, federal, and for-
eign law enforcement agencies and improved communication with
drug manufacturers."' 7
However, despite the increased awareness and efforts by the FDA
to prevent the introduction of counterfeits into the United States, many
patients and consumers remain unaware of the problem and continue
to purchase medicines from unapproved sources. Additionally, there
is a "potential for an increase in the number of counterfeit[s] [in the
United States] because of the increasing global nature of the pharma-
ceutical business and the ease with which counterfeit products can be
distributed by 'pharmacies'... on the Internet, by drug diverters, and
by other sources outside the prescription system."' 8 Patients and the
public at large need to be provided with information and education
about the increasing threat to their safety that counterfeit drugs pose.
As direct health care providers, nurses can play a crucial role in not
12. Id. at 1.
13. Press Release, U.S. Dep't of Health & Human Servs., HHS Takes New Steps to
Protect Consumers from Counterfeit Drug Threats (Feb. 18, 2004), http://www.hhs.gov/news/
press/2004pres/20040218.html.
14. Press Release, FDA, FDA Continues Combating Counterfeit Drugs Annual Update
Reports on Progress (May 18, 2005), http://www.fda.gov/bbs/topics/NEWS/2005/
NEW01 179.html.
15. Id.
16. Id.
17. Id.
18. Douglas W. Steam, Deterring the Importation of Counterfeit Pharmaceutical Prod-
ucts, 59 FOOD & DRUG L.J. 537, 541 (2004).
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only screening for counterfeit medicines, but also in reporting counter-
feit products and providing the necessary information and education. 9
COUNTERFEIT DRUGS INCREASE THE RISK TO
PATIENTS' HEALTH AND SAFETY
The Scope
The World Health Organization defines counterfeit medicines as
those that are "deliberately... mislabeled with respect to identity and/or
source."2a The term pertains to both brand name and generic prod-
ucts.2' Counterfeit medicines can "include products with the correct
ingredients but fake packaging, [products] with the wrong ingredients,
[products] without the active ingredients, or [products] with insuffi-
cient active ingredients."2
Counterfeit drugs are "look-alike" products that contain little or
no active ingredients or possibly harmful ingredients.23 Counterfeits
also include rejected medicines that have been kept off the market by
the manufacturer or regulatory authorities for quality reasons, and re-
labeled medications that have expired but have been repackaged and
remarketed with a later expiration date.24 Identical copies or counter-
feit products manufactured with the same ingredients, formulation,
and packaging are not as common.25
The most frequently counterfeited medicines in the wealthier,
more affluent countries are expensive lifestyle medicines such as
hormones, steroids, and antihistamines. 26 In fact, one of the most fre-
quently counterfeited drugs has been Viagra, which is sold extensively
on the Internet. 27 Medicines to treat life-threatening conditions such
as malaria, tuberculosis, and HIV/AIDS are the most counterfeited
medicines in developing countries.2 s
19. INT'L COUNCIL OF NURSES, supra note 1, at 9.
20. Fact Sheet No. 275, supra note 8.
21. Id.
22. Id.
23. Albert I. Wertheimer et al., Counterfeit Pharmaceuticals: Current Status and Future
Projections, 43(6) J. AM. PHARMACEUTICAL ASS'N 666 (2003).
24. Id.
25. See id. at 2.
26. Fact Sheet No. 275, supra note 8.
27. Id.
28. Id.
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The Effects
Counterfeit medicines can have serious, life-threatening effects
for patients taking them. "Each type of counterfeit drug can affect a
victim in a different way" and injury "can be caused by the lack of ac-
tive ingredients or the presence of harmful agents."2 9 Some of the ma-
jor consequences of taking counterfeit drugs include treatment fail-
ures, prolonged illness, unexpected side effects, antimicrobial
resistance, and even death.30 The regular use of counterfeits by an un-
suspecting patient would minimally lead to therapeutic failure or drug
resistance.3 The most severe consequence is death.32
The damage caused by counterfeit drugs is not confined to the in-
dividual patient consuming the product but extends to all of society.33
Medications that lack active ingredients or deliver sub-therapeutic
doses endanger the public health. In particular, anti-infectives con-
tribute to the global problem of increasing drug resistant organisms.
3 4
THE NURSING ROLE
Nurses play an integral role in the care of patients and their medi-
cines. Nurses receive orders, administer medicines, monitor effects
and side effects, and educate patients about their medicines in a vari-
ety of settings. Because of their role, nurses are well-positioned to as-
sist in the fight against counterfeit drugs and to educate patients and
other providers about the dangers of consuming counterfeit medicines.
Nurses, as frontline health care providers, can be key players to
vigilantly attempt to identify counterfeit drugs and report possible
counterfeit products.3" For example, while examining and administer-
ing medications, "nurses can assist in the identification of counterfeit
products by direct observation of people and products."36  Further,
nurses can monitor the product by looking for visible variations in ap-
pearance, packaging, and labeling of the drug.37 Nurses can also
monitor patients when they report the medicine has no effect or has an
29. Id.
30. INT'L COUNCIL OF NURSES, supra note 1, at 5.
31. Fact Sheet No. 275, supra note 8.
32. Id.
33. Wertheimer et al., supra note 23.
34. Id.
35. INT'L COUNCIL OF NURSES, supra note 1, at 5, 19.
36. Id. at 19.
37. Id.
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effect that is different from the expected outcome.38 While dispensing
medications, nurses should also look for "products that are not intact,
that have been altered, damaged or that have unsealed packaging."3 9
Nurses should inquire about the price of the products purchased be-
cause very low prices are another primary indicator of counterfeit
medicines. 4 Additionally, nurses should educate their patients about
all of these indicators so the patients themselves can avoid counterfeit
drugs.
Indeed, in various health care settings, nurses can also routinely
"monitor drug effects and side effects and must be vigilant for signs of
counterfeiting."' 4' Nurses can therefore play a key role in educating
the public about the dangers of buying medicines through the Internet,
from street corners, in foreign countries, and from other unauthorized
sources. Nurses who uncover counterfeit drugs can report suspected
cases to the appropriate authority. Finally, nurses can guide patients
to resources to protect themselves.42
NURSING AWARENESS
As direct care providers and because patients place them in a posi-
tion of trust, nurses are in the ideal position to intervene on behalf of
patients and to provide education, monitoring, and reporting of coun-
terfeit drugs. However, the reality at the current time is that within the
nursing culture, there is no index of suspicion about counterfeit drugs.
Nurses, particularly in the United States, usually do not ask to see pa-
tients' medications, nor do nurses ask where patients purchase their
medications. Moreover, nurses are usually unable to recognize coun-
terfeit drugs. In order for nurses to participate in the battle against
counterfeit medicines, they themselves must be provided with suffi-
cient information and education.
During International Nurses Day 2005, the International Council
of Nurses (ICN) recognized the importance of this topic, the general
lack of awareness about it, and possible tools to fight counterfeit
drugs. The ICN chose counterfeit drugs as their topic at International
Nurses Day 2005 to provide nurses with the relevant means and meth-
ods to deal with this increasing patient safety problem.43 The goals of
38. Id.
39. Id.
40. Id.
41. Id. at 5.
42. Id. at 20.
43. Id. at 5.
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the campaign are numerous: to educate nurses, health professionals,
and patients about the dangers of counterfeit drugs; to increase aware-
ness of the existence and consequences of counterfeit medicines; to
provide tools to identify counterfeit drugs; to report any suspicious
medicines; and to support regulatory authorities in their fight against
counterfeit drugs.4 By providing the necessary information and edu-
cation to nurses, nurses everywhere can begin to educate patients, in-
crease monitoring for counterfeits, report suspected cases to authori-
ties, and support regulatory efforts to prevent counterfeit drugs from
entering the drug distribution system. 45
Such an approach is a strong and important beginning. At the
present time, nurses have the ability, but do not have the knowledge,
to protect patients against potential fake medicines in clinics and in
hospital wards. However, the culture of nursing still has a consider-
able distance to go before additional risks of medicine safety are
placed upon the health delivery system. Important weaknesses in drug
safety as experienced by patients due to problems in FDA oversight,
drug importation, and nursing staff shortages create additional pres-
sures and burdens that prevent nurses from being able to advocate for
the safety of their patients in this crucial area of care. Attention must
be focused on the practical nature of the culture of health care delivery
to understand what policy proposals can improve health care for a par-
ticular society. Part of that assessment should be how patients can be
protected based on the resources, knowledge, and tools nurses have to
carry out their ethical duty to the patient. With the problem of coun-
terfeit drugs increasing in developed and less-developed countries, it
is incumbent upon policymakers to ensure that the risks to patients are
not increased through policies that would require overburdened pro-
viders and agencies to assume additional responsibilities they are cur-
rently unable to engage in, however much they wish to.
CONCLUSION
Drug counterfeiting is no longer confined to developing countries;
it has become a global problem.4 6 With increased free trade and usage
of online pharmacies, counterfeit drugs are even reaching developed
countries, such as the United Sates, that have well-established drug
44. Id.
45. Id.
46. Id.
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policies and regulations. 47 Thus, drug counterfeiting poses serious
public health and safety concerns. Counterfeits may pose an even
greater threat in the future if preventative measures are not taken
now.48 As counterfeiters find new procedures "to make deceptive
products and introduce them into legitimate commerce, our systems
for protecting patients must respond effectively" and much more pro-
actively. 49 As frontline care providers, nurses can play a key role in
the battle against counterfeit drugs. However, policies that create ad-
ditional responsibilities for those accountable for ensuring safety,
frontline providers and overseeing agencies, should be sensitive to the
risks inherent in asking each to do more when the culture and re-
sources are inadequate to reasonably perform their duties now.
47. Wertheimer et a]., supra note 23.
48. FDA, supra note 3, at 1.
49. Id. at 1-2.
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